Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Strategic Asset Allocation Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Strategic Asset Allocation Index of 48.8% as of June 2023. Strategic assets (PP&E of CN¥2.49 Billion plus long-term investments of CN¥-) total CN¥2.49 Billion, measured against net assets of CN¥5.11 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 600557 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Jiangsu Kanion Pharmaceutical Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Jiangsu Kanion Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 48.8%, representing strategic assets of CN¥2.49 Billion against net assets of CN¥5.11 Billion CNY. See Jiangsu Kanion Pharmaceutical Co Ltd (600557) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Jiangsu Kanion Pharmaceutical Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Kanion Pharmaceutical Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 600557 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 50.8% | CN¥2.51 Billion | CN¥2.51 Billion | CN¥- | CN¥4.93 Billion | ▼ -5.8 pp |
| 2021 | 56.6% | CN¥2.53 Billion | CN¥2.53 Billion | CN¥- | CN¥4.47 Billion | ▼ -2.5 pp |
| 2020 | 59.1% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥4.33 Billion | ▲ +0.4 pp |
| 2019 | 58.7% | CN¥2.40 Billion | CN¥2.40 Billion | CN¥- | CN¥4.09 Billion | ▼ -2.2 pp |
| 2018 | 60.9% | CN¥2.37 Billion | CN¥2.19 Billion | CN¥175.72 Million | CN¥3.89 Billion | ▲ +4.1 pp |
| 2017 | 56.7% | CN¥2.04 Billion | CN¥1.89 Billion | CN¥151.72 Million | CN¥3.59 Billion | ▼ -2.6 pp |
| 2016 | 59.4% | CN¥1.90 Billion | CN¥1.88 Billion | CN¥24.63 Million | CN¥3.21 Billion | ▼ -0.5 pp |
| 2015 | 59.9% | CN¥1.72 Billion | CN¥1.72 Billion | CN¥3.98 Million | CN¥2.87 Billion | ▲ +1.5 pp |
| 2014 | 58.4% | CN¥1.49 Billion | CN¥1.49 Billion | CN¥- | CN¥2.56 Billion | ▼ -16.6 pp |
| 2013 | 75.0% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥1.93 Billion | ▲ +9.1 pp |
| 2012 | 66.0% | CN¥1.09 Billion | CN¥1.09 Billion | CN¥- | CN¥1.65 Billion | ▲ +5.4 pp |
| 2011 | 60.5% | CN¥892.62 Million | CN¥892.62 Million | CN¥- | CN¥1.47 Billion | ▼ -1.5 pp |
| 2010 | 62.0% | CN¥771.79 Million | CN¥771.79 Million | CN¥- | CN¥1.24 Billion | ▲ +16.6 pp |
| 2009 | 45.4% | CN¥489.83 Million | CN¥489.83 Million | CN¥- | CN¥1.08 Billion | ▼ -1.9 pp |
| 2008 | 47.3% | CN¥451.96 Million | CN¥451.96 Million | CN¥- | CN¥954.72 Million | ▼ -30.7 pp |
| 2007 | 78.0% | CN¥435.46 Million | CN¥435.46 Million | CN¥- | CN¥557.95 Million | ▼ -3.9 pp |
| 2006 | 81.9% | CN¥403.76 Million | CN¥403.76 Million | CN¥- | CN¥492.91 Million | ▼ -11.6 pp |
| 2005 | 93.5% | CN¥428.35 Million | CN¥428.35 Million | CN¥- | CN¥457.89 Million | ▲ +12.4 pp |
| 2004 | 81.2% | CN¥336.04 Million | CN¥336.04 Million | CN¥- | CN¥414.10 Million | ▲ +10.6 pp |
| 2003 | 70.5% | CN¥264.47 Million | CN¥264.47 Million | CN¥- | CN¥374.88 Million | ▲ +30.7 pp |
| 2002 | 39.8% | CN¥132.84 Million | CN¥132.84 Million | CN¥- | CN¥333.38 Million | ▼ -24.2 pp |
| 2001 | 64.1% | CN¥47.35 Million | CN¥47.35 Million | CN¥- | CN¥73.91 Million | ▲ +6.0 pp |
| 2000 | 58.1% | CN¥33.12 Million | CN¥33.12 Million | CN¥- | CN¥57.01 Million | — |